Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial

• Nathan R. Hill,
• Daniel Lasserson,
• Ben Thompson,
• Rafael Perera-Salazar,
• Jane Wolstenholme,
• Peter Bower,
• Thomas Blakeman,
• David Fitzmaurice,
• Paul Little,
• Gene Feder,
• Nadeem Qureshi,
• Maarten Taal,
• Jonathan Townend,
• Charles Ferro,
• Richard McManus,
• F. D. Richard Hobbs

Affiliations

Nathan R. Hill

Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter

Daniel Lasserson

Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter

Ben Thompson

Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter

Rafael Perera-Salazar

Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter

Jane Wolstenholme

Department of Public Health, University of Oxford

Peter Bower

Centre for Primary Care, Institute of Population Health, University of Manchester

Thomas Blakeman

Centre for Primary Care, Institute of Population Health, University of Manchester

David Fitzmaurice

Primary Care Clinical Sciences, School of Health and Population Sciences, College of Medical and Dental Sciences, University of Birmingham

Paul Little

Primary Medical Care, University of Southampton, Aldermoor Health Centre

Gene Feder

School of Social and Community Medicine, University of Bristol

Nadeem Qureshi

School of Medicine

Maarten Taal

Department of Renal Medicine, Royal Derby Hospital

Jonathan Townend

Cardio-Renal Research Group, Departments of Cardiology and Nephrology, Queen Elizabeth Hospital Birmingham and University of Birmingham

Charles Ferro

Cardio-Renal Research Group, Departments of Cardiology and Nephrology, Queen Elizabeth Hospital Birmingham and University of Birmingham

Richard McManus

Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter

F. D. Richard Hobbs

Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter